EU approves skin cancer fighting drug: Roche
Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.
Cancer
Feb 20, 2012 |
5 / 5 (1) |
0
Novel gene mutations associated with bile duct cancer
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited. ...
Cancer
Jan 18, 2012 |
not rated yet |
0
|
Study examines accuracy of prognostic tools used to predict mortality among older adults
A review of 16 prognostic indices used to predict risk of death in older adults in a variety of clinical settings, such as in nursing homes and hospitals, found that there is insufficient evidence to recommend the widespread ...
Other
Jan 10, 2012 |
not rated yet |
0
UK researchers present findings from Kentucky breast cancer patients with disease relapse
The University of Kentucky Markey Cancer Center breast oncologist Dr. Suleiman Massarweh and his research team presented findings from their studies on relapse of breast cancer at the San Antonio Breast Cancer Symposium this ...
Cancer
Dec 23, 2011 |
not rated yet |
0
Molecular markers can predict spread of cancer, guide treatment
Molecular markers found in cancer cells that have spread from a primary tumor to a limited number of distant sites can help physicians predict which patients with metastatic cancer will benefit from aggressive, targeted radiation ...
Cancer
Dec 13, 2011 |
not rated yet |
0
Breast cancer patients face increasing number of imaging visits before surgery
Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand ...
Surgery
Dec 09, 2011 |
not rated yet |
0
Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer
Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from ...
Cancer
Dec 08, 2011 |
not rated yet |
0
Anti-estrogen combo better than single drug for hormone-sensitive breast cancer
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were ...
Cancer
Dec 07, 2011 |
not rated yet |
0
|
Researchers discover how breast cancer spreads to lung
The spread of breast cancer is responsible for more than 90 percent of breast cancer deaths. Now, the process by which it spreads -- or metastasizes -- has been unraveled by researchers at Johns Hopkins.
Cancer
Nov 16, 2011 |
3 / 5 (1) |
0
|
Vaccine for metastatic breast, ovarian cancer shows promise
Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and ovarian cancer, according to a trial published in Clinical Cancer Research, a journal of the American Association for Ca ...
Cancer
Nov 08, 2011 |
not rated yet |
0
|
Scientists find approach to enhance and prolong immune attack against tumor cells
(Medical Xpress) -- Investigators have identified a new class of human immune cells that behave like stem cells. These cells, a subtype of T lymphocytes, which comprise a small fraction of white blood cells, may prove more ...
Cancer
Sep 21, 2011 |
5 / 5 (1) |
0
|
New protein may suppress breast cancer growth
Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, has found that a protein discovered by ...
Cancer
Sep 14, 2011 |
not rated yet |
0
|
Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.
Cancer
Jul 18, 2011 |
not rated yet |
0
Novel combined therapy extends life, diminishes pain in brain cancer patients
Approximately five to ten percent of patients with primary or metastatic cancer suffer from devastating neurological complications such as headaches, seizures, confusion, difficulty swallowing and visual disturbances. ...
Cancer
Jul 14, 2011 |
not rated yet |
0
Early-stage melanoma tumors contain clues to metastatic potential
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal.
Cancer
Jul 14, 2011 |
not rated yet |
2
|
